Market Overview - The A-share market experienced a decline, with the Shanghai Composite Index closing at 4075.92, down 0.64%, and the Shenzhen Component Index down 1.44% at 13952.71 [8][9] - The overall market sentiment showed a decrease in trading volume, with total market turnover at 21,942.8 billion, a reduction of 3,089.83 billion from the previous trading day [9][11] Industry Dynamics - The brain-computer interface company, Borui Kang, has initiated its listing guidance, indicating growth in the tech sector [26] - The photovoltaic industry is expected to maintain stable installation levels during the 14th Five-Year Plan, with annual new installations projected between 238-287 GW in China [28] - The global liquid crystal television panel shipment is forecasted to increase by 3.4% in 2025, with mainland manufacturers surpassing a 70% market share for the first time [30] - The global display market is expected to grow by 1.1% in 2025, driven by a significant increase in OLED display shipments [33] Company Updates - Qilu Bank reported a 5.12% year-on-year increase in operating revenue for 2025, reaching 13.135 billion, with net profit rising by 14.58% to 5.713 billion [39][41] - The company maintained a non-performing loan ratio of 1.05%, a decrease of 0.14 percentage points from the previous year, indicating improved asset quality [41] Economic Insights - In January 2026, 4.92 million new A-share accounts were opened, a 213% increase year-on-year, reflecting growing investor interest [35] - The logistics industry in China reported a January 2026 business activity index of 51.2, indicating continued expansion despite a slight month-on-month decline [17]

Company Overview - Brain-computer interface company, BoRuiKang Technology (Shanghai) Co., Ltd., has completed its IPO counseling registration on February 4, 2026, with CITIC Securities as the counseling broker, marking the official start of its Sci-Tech Innovation Board IPO process [1][2][3] - Established in November 2011, BoRuiKang's core team includes experts from Tsinghua University's Neural Engineering Laboratory and clinical neuroscience, focusing on the research, production, and technical services of brain-computer interface systems [3][4] - The company has developed products for clinical diagnosis and research education, including digital EEG machines and transcranial electrical stimulation systems, with some products already receiving medical device registration [3][4] Product Development - BoRuiKang's flagship product, the NEO wireless minimally invasive brain-computer interface system, is the world's first to use an epidural implant with fully wireless transmission design [3][4] - NEO employs a "semi-invasive" technique, implanting coin-sized electrodes beneath the skull but outside the dura mater, allowing proximity to neurons without direct contact, thus avoiding damage to neural tissue [4] - The NEO system has undergone successful clinical trials, with 32 patients having completed implantation across 11 hospitals, achieving a 100% success rate in primary clinical endpoints [4][5] Regulatory Progress - NEO is set to submit a Class III innovative medical device registration application to the National Medical Products Administration, potentially becoming the first marketed implantable brain-computer interface product in China [5] - The product's first version, NEO 1.0, is expected to be followed by a 2.0 version that will include additional features such as language decoding and small limb decoding [5] Financial Backing and Valuation - BoRuiKang has completed multiple rounds of financing, with notable investors including Sequoia China and Baidu Ventures, achieving a post-investment valuation of 3.5 to 4 billion yuan by the end of 2025 [5][6] - The company has raised a total of 1.2 million yuan in angel funding and 30 million yuan in Pre-A funding, among other financing rounds [5] Industry Context - The brain-computer interface industry is experiencing significant growth opportunities in China, supported by favorable policies and market conditions [9][10] - The Ministry of Industry and Information Technology and other departments have included brain-computer interfaces in key future industry cultivation, with projections indicating the market could exceed 120 billion yuan by 2040 [10]

□ 本报记者马薇整理 二是努力推动太湖水质根本好转。认真抓好中央巡视反馈问题整改，高标准开展新一轮太湖治理，深化 湖岸同治、流域共治，扎实做好清淤、控源、截污等各项工作，确保太湖无锡水域水质稳定达到Ⅲ类。 同时以太湖治理为牵引，协同推进降碳、减污、扩绿、增长，以"人文家的心、艺术家的眼、科学家的 智"规划建设城市，做好生态"+品牌""+文旅""+消费"等文章，于青山绿水间打造人口、人力、人才、人 气同步增长的高品质宜居城市。 三是努力推动全体人民共同富裕。坚持在发展中保障和改善民生，坚持投资于物和投资于人紧密结合， 进一步健全与人口变化相适应的公共资源配置机制、国企牵头的微利型社会公用事业发展模式，探索集 团化办学、医联体建设、医养结合、老幼共托、科技助残等新路径，解决好群众普遍关心的学校学位、 医院床位、就业岗位等问题，统筹推进高品质生活、高效能治理、高水平安全，加快建设人民满意的共 同富裕幸福美好城市。 总之，无锡将按照省两会的部署要求，树立和践行"为人民出政绩、以实干出政绩"的正确政绩观，聚力 聚焦，狠抓落实，努力为全省发展大局作出新的更大贡献。 2026年是"十五五"开局之年，无锡将继续把深入贯彻习近 ...

转自：成都日报锦观 政企新春座谈会"零距离" 企业提诉求 部门现场办 本报讯 （成都日报锦观新闻记者 黄欢） "人才认定能否多些自主空间？""想在锦江落地卫星应用示范 场景。""白鹭湾地铁开通能否提速？"2月5日，"共赋高成长 共创新生态"2026年锦江区高成长企业新春 座谈会现场，企业家们不仅讲成绩，更是直接提诉求，锦江区科技局、人才办、应急局等部门负责人面 对面回应、实打实对接，政企双向奔赴的热乎劲儿，让这个新春暖意融融。 在座谈会上，成都芯脑科技、星元空间、凝思软件等企业诉求刚说完，部门回应马上到。锦江区人才办 现场承诺，硕士以上人才可通过小程序10—15个工作日办结认定，并进一步优化探索"一企一策"支持； 区科技局明确联合芯脑科技申报脑机接口省级制造业创新中心，尽快启动产业数据库共建；区应急局主 动牵手星元空间，谋划"卫星+应急"合作，布局应急产业园区；针对交通诉求，相关部门表示将提速地 铁前期工作，同步优化公交接驳。 "企业的声音就是政府工作的风向标。"锦江区委相关负责人表示，此次座谈会既是政企沟通桥，也是政 策校准器。下一步，锦江区将深化"白鹭计划"，依托高成长企业发展促进中心，以全链条服务破解发 ...

Group 1 - The core idea of the news is that Elon Musk's business empire is accelerating vertical integration, with SpaceX acquiring xAI, which previously merged with social platform X, creating a super entity focused on space data centers and AI computing energy breakthroughs [2] - The "Big X Group" is a loose alliance centered around SpaceX, integrating xAI and X, with a valuation exceeding $1.25 trillion, and includes Tesla, The Boring Company, and Neuralink [2] - Musk's acquisition history shows a preference for centralized control, as seen with Tesla's $2 billion investment in xAI, indicating a potential for Neuralink to be integrated into the "Big X Group" to enhance overall valuation and support SpaceX's IPO plans [6] Group 2 - Neuralink, founded in 2016, focuses on invasive brain-machine interfaces, with plans for human implantation in 2024 and expansion into text translation and thought control by 2025 [5] - The synergy potential between Neuralink and xAI is significant, as xAI's Grok relies on real-time data, while Neuralink provides a direct interface for human thought, enabling a closed-loop brain-machine ecosystem [5][6] - Regulatory barriers are high for Neuralink due to its medical device nature, which may lead to data privacy and ethical concerns if integrated into a commercial entity like SpaceX or xAI [6] Group 3 - The probability of integration between Neuralink and the "Big X Group" is high, potentially occurring by late 2026 or early 2027, as Neuralink is seen as a key component in Musk's vision of understanding the universe [7] - If integration occurs, it would signify a leap towards a "super entity" that merges AI, space, and human intelligence, while if it does not happen, Neuralink may remain independent or align more closely with Tesla [7]

中新社天津2月5日电 (记者孙玲玲)全国首届脑机接口开发者大会近日在天津举行，会上揭晓"华瑙— 2025年度中国脑机接口十大进展"，其详细内容于5日晚正式对外发布。这些成果标志着中国脑机接口技 术正加速从实验室走向产业一线。 本次发布的十大进展聚焦产业核心环节：在标准层面，脑机接口医疗器械基础术语行业标准发布，填补 了标准体系空白；在技术前沿，可泛化与可解释的癫痫发作预测脑电大模型取得关键突破，首创融合大 语言模型的脑电—语义转换新范式；在临床转化上，"北脑一号"智能脑机系统植入式设备开展多中心临 床试验，已完成多例人体植入手术。 天津市环湖医院副院长岳伟参加上述大会时介绍，医院与脑机海河实验室以临床需求为导向，推动科研 创新成果精准对接临床需求，已形成包括上下肢运动康复、精神诊疗、神经重症等多项脑机接口临床综 合解决方案。 《加快北京市脑机接口创新发展行动方案(2025—2030年)》近日印发，系统规划了打造高水平脑机接口 创新与产业高地的蓝图；全国首个脑机接口未来产业集聚区"脑智天地"在上海启动；今年天津市政府工 作报告提出，其将争建国家脑机接口技术创新中心；江苏等地也通过设立省级研究院等方式推动产学研 ...

Core Viewpoint - The market is experiencing a phase of adjustment after a period of overheating, primarily due to expectations of tightening overseas liquidity and pressure from cyclical sector corrections [1][5]. Group 1: Market Outlook - February is identified as a rare performance vacuum period, with a stable situation in the Asia-Pacific region; however, the extended Spring Festival may lead to early profit-taking by some funds [6]. - The market is expected to exhibit a volatile pattern, emphasizing the importance of stock selection [6]. Group 2: Investment Opportunities in Medical Technology - The company remains optimistic about the ongoing wave of technological innovation in the medical and consumer sectors, particularly driven by AI and domestic industry advancements, which present investment opportunities in the Chinese capital market [7][8]. - Key areas of focus include AI in healthcare, brain-computer interfaces, surgical robots, AI-driven innovative drugs, innovative medical devices, and cell gene nucleic acid therapies [7][8]. Group 3: New Logic for Innovative Drugs - The previous BD (business development) trading model for innovative drugs is losing effectiveness, necessitating a new guiding logic for the capital market to foster a new market trend [9]. - Three potential directions for innovative drugs are identified: 1. Core value return, where the globalization of domestic innovative drugs does not require excessive speculation 2. Performance explosion, with some outbound platform-type innovative drug companies expected to show nonlinear profit releases 3. Positive cycle of BD trading, where market sentiment is cyclical, transitioning from excessive enthusiasm to extreme lows, leading to a significant drop in overseas BD expectations for many companies [9].

来源：@消费者报道微博 【#国内脑机接口相关企业超650家#，#脑机接口商业化转向医疗健康领域#】2026年1月，OpenAI创始 人萨姆・奥尔特曼以联合创始人身份创立脑机接口公司Merge Labs；马斯克旗下Neuralink官宣年内启动 设备量产。受此影响，全球脑机接口热度攀升，中国市场也持续活跃，截至2026年1月，国内相关企业 数量已超650家，2025年新增注册量同比增长约50%。 近年来，脑机接口企业正加速从消费场景转向医疗健康领域。这一转变的背后，是全球脑卒中、帕金森 病等神经系统疾病患者数量持续增长，而传统医疗手段效果有限，存在大量未满足的临床需求。 然而，从技术落地到全面普惠仍面临多重挑战。侵入式脑机接口单套设备成本超过50万元，非侵入式产 品也对部分家庭构成经济压力。北京康复医院党委副书记、院长盖海山呼吁构建"医保+商保+个人支 付"多元体系以降低负担。@蓝鲸新闻 来源：@消费者报道微博 【#国内脑机接口相关企业超650家#，#脑机接口商业化转向医疗健康领域#】2026年1月，OpenAI创始 人萨姆・奥尔特曼以联合创始人身份创立脑机接口公司Merge Labs；马斯克旗下Neurali ...

又一家脑机接口（BCI）公司，筹备IPO。 | 辅导协议签署 | 2026年2月4日 | | --- | --- | | 时 间 | | | 辅 导 机 构 | 中信证券股份有限公司 | | 律师事务所 | 北京市通商律师事务所 | | 会计师事务所 | 天健会计师事务所(特殊普通合伙) | 来源：证监会官网截图 今年1月12日有消息称，强脑科技被爆以保密形式提交香港IPO申请；另据外媒2025年8月消息，该公司正以超13亿美元估值洽谈约1亿美元的IPO前融资， 或为后续在香港或内地IPO铺路。 值得一提的是，据新华网消息，从实验室里第一束脑电波纹被捕捉，到2025年我国市场规模突破38亿元，脑机接口在中国正完成从"产学研"到"用"的关键 一跃。 我国"十五五"规划明确提出推动脑机接口成为新的经济增长点，上海、深圳等地直接设立数十亿元规模的脑机接口、脑科学（核心股）专项基金。 2月4日，脑机接口技术研发商博睿康技术（上海）股份有限公司（下称：博睿康），在上海证监局进行上市辅导备案，辅导机构为中信证券。 | 辅导对象 | 博睿康技术(上海)股份有限公司 | | --- | --- | | 成立日期 | 2011 ...

Core Viewpoint - The article highlights the advancements and potential of brain-computer interface (BCI) technology, particularly through the efforts of Qiangnao Technology, which aims to help disabled individuals regain mobility and improve their quality of life [6][10]. Group 1: Event Overview - The "Entrepreneur Night" event took place on January 29 in Beijing, where Qiangnao Technology's CEO Han Bicheng was honored [3]. - Guests included Gao Dekang, Chairman of Bosideng, and Yin Ye, CEO of BGI, who praised Qiangnao Technology for its innovative contributions [4][5]. Group 2: Company Mission and Goals - Qiangnao Technology aims to use advanced technology, specifically thought control, to assist individuals with disabilities in regaining limbs and improving their daily lives [6][14]. - The company has set a goal to help 1 million disabled individuals regain mobility within the next 5 to 10 years [7][14]. Group 3: Technology Development - The development of BCI technology has transitioned from a long experimental phase to a recent period of industrial application, marking a significant milestone for the industry [9]. - Qiangnao Technology represents a key player in making BCI technology accessible and practical for everyday use, moving beyond theoretical applications [10]. Group 4: Technical Challenges and Innovations - The primary challenges in BCI technology include data collection and analysis due to the complexity of the human brain, which contains billions of neurons [11]. - The integration of AI technology is expected to enhance the capabilities of BCI, allowing for more precise control of prosthetics and other applications [11]. Group 5: Policy Support and Future Outlook - The Chinese government's "14th Five-Year Plan" has recognized BCI as one of the six key future industries, indicating strong policy support for its development [12]. - BCI technology offers new intervention possibilities for brain-related health issues, potentially transforming the medical field by providing non-chemical solutions [12].